MICHAEL MORGAN NAMED ONE OF THE 2022 PM360 ELITE 100
NEW YORK, NY, MAY 23, 2022 — PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Michael Morgan, Senior Vice President of Business Development, Mesmerize as one of the 2022 PM360 ELITE 100 in the Leaders of the Future category. Now in its eighth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today.
Michael Morgan has proved to be a leader in a myriad of areas in a short amount of time, from leading unequivocal growth within Mesmerize and a growing team to leading change in the stigma around HIV and AIDS. When Michael joined Mesmerize as the Director of Digital Business Development in 2019, he led a team and managed point-of-care TV screens in independent pharmacies. After just two years, Michael is now leading a substantial team with and expanded the patient education network to include many screens in pharmacies, doctors’ offices, community-based organizations, and clinics — resulting in over 100% year-over-year revenue growth.
“Since Michael joined Mesmerize in July 2019, he’s had tremendous impact across Mesmerize and has been instrumental in shaping the vision for our digital point of care network,” said Michael Ellis, Mesmerize Chief Operating Officer. “Perhaps most importantly, Michael has been a valued mentor for many Mesmerize staff and is active in helping to cultivate the next level of leaders in the company. He is recognized across the company as a transformational leader and could not be more deserving of PM360’s Leaders of the Future award.”
The PM360 ELITE Awards were established in 2015 to recognize individuals and teams who have made a significant impact on the life sciences and healthcare industries throughout their careers. More than 500 submissions were received and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 20 categories, including Creative Directors, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Environmental Champions, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, Philanthropic Heroes, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.
“Our industry accomplished great things during the pandemic to ensure people could be protected against COVID, treated for it, and still access all of the other medications they need, but this disruption to our world also revealed ways in which our industry could be even better,” says Anna Stashower, CEO and Publisher of PM360. “Many of this year’s winners sprang into action to improve areas the pandemic exposed as needing changes, including addressing health equity, social determinants of health, clinical research, patient access and affordability, and much more. That’s what makes them the most influential people our industry has to offer—their ability to push the industry forward to make healthcare better for all.”
The winners were profiled in PM360’s May 2022 issue. You can read Michael’s profile online at https://www.pm360online.com/elite-2022-leader-of-the-future-michael-morgan-of-mesmerize/
Additionally, the 2022 ELITE 100 will be celebrated at the annual ELITE Awards Event, which will be held at 230 FIFTH in New York City on July 13th starting at 7 PM EST. A special keynote address from Uber ELITE Winner Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, Worldwide Research, Development, and Medical, Pfizer Inc., will kick-off the celebration.
Tickets for the event can be purchased at https://www.pm360online.com/elitetickets.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
Mesmerize is a media company that specializes in patient education at the point of care. Mesmerize provides targeted educational materials including digital and static wallboards, literature distribution, and branded medical essentials to patients and caregivers in waiting rooms, exam rooms, and other high traffic areas of doctors' offices, community-based organizations, AIDS service organizations, and independent and chain pharmacies. For more information, please visit www.mesmerize.com